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Resistance to infection with intracellular bacteria such as Listeria  monocytogenes 
is cell-mediated and requires the participation of both lymphoid cells and mononuclear 
phagocytes (1). During the course of a  nonlethal infection there arises a  population 
of specifically sensitized lymphocytes that are capable of passively transferring im- 
munity to normal mice (2). This passive transfer requires the accumulation of recipient 
macrophages at the sites of Listeria  infection, for it is the macrophage which is the 
ultimate effector cell that rids the  host of the  bacteria  (3).  Once  activated by the 
specifically sensitized lymphocytes in  the  presence  of Listeria  antigen,  the  macro- 
phages act nonspecifically, i.e., they will protect against infection with an unrelated 
bacterial pathogen (3,  4). The mechanism of activation of macrophages by lympho- 
cytes is not known,  but may be through the release of one or more of the lympho- 
kines, as described for in vitro correlates of delayed hypersensitivity (5, 6). 
Prendergast and Suzuki (7)  have described a  protein having a  tool wt of 32,000, 
isolated from the coelomocytes of the sea star (Asteriasforbesi),  that acts in a manner 
analogous to the mediators of delayed hypersensitivity. This sea star factor  (SSF)  1 
has the following characteristics: (a) it causes a  skin reaction in nonsensitized guinea 
pigs which  is identical both  temporally and  cytologically to  a  delayed hypersensi- 
tivity-type skin reaction;  (b)  it inhibits the migration of normal guinea pig macro- 
phages from capillary tubes;  (c)  it is chemotactic for macrophages; and  (d)  macro- 
phages treated either in vivo or in vitro with SSF are morphologically altered to an 
"activated" form  (8,  9). 
Because of these macrophage-activating properties, we examined  the  effect 
of SSF on mice infected with Listeria where activation of macrophages is im- 
portant  as a  defense mechanism.  We postulated  that  enhanced  resistances of 
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mice  to  Listeria  would  result  after  nonspecifically  activating  their  macro- 
phages with SSF.  Mice treated with SSF, however, become more susceptible to 
Listeria infection rather  than more resistant.  The  results of these experiments 
suggest  that,  rather  than  activating  macrophages,  SSF  inhibits  the  immune 
response to Listeria and does so at the level of the lymphocyte. 
Materials and Methods 
A nimals.--Female pathogen-free outbred Swiss-Webster mice aged 4-6 wk were used (Flow 
Laboratories, Inc., Rockville, Md.) 
Organisms.--Listeria  monacytogenes, strain EGD,  was obtained from Dr. George Macka- 
ness of the Trudeau Institute, and was maintained by passage in ICR mice. Organisms for 
injection were obtained from an 18-24 h  culture of infected spleen grown in trypticase soy 
broth (Difco Laboratories, Detroit, Mich.). Organismswere counted in a Petroff-Hausser count- 
ing chamber (Arthur l-I. Thomas Co., Philadelphia, Pa.) and diluted in Hanks' balanced salt 
solution (HBSS)  for  injection. Viable counts were  confirmed  by plating  an  aliquot of  the 
culture on trypticase soy agar. 
Sea Star Factor (SSF).--SSF was prepared as described previously  (7). Briefly, coelomo- 
cytes collected from the sea star (Asteriasforbesi) were lysed by three cycles of freeze-thawing, 
followed by brief ultrasonication. This product was centrifuged at 60,000 g for 90 rain and the 
clear supernate removed and dialyzed  against phosphate buffered  saline pH  7.2 for  24 h, 
then centrifuged again at 60,000 g for 50 rain, and the supernate recovered and sterilized by 
passage through a  0.45 micron Millipore filter (Millipore Corp.,  Bedford, Mass.).  SSF was 
stored at --20°C until use. 
Measurement of Immunlty.--Immunity, active or passive, was measured by enumerating 
the number of viable Listeria in livers and spleens of mice at various times after infection. 
Initial implantation was determined by assaying the number of Listeria in livers and spleens 
harvested at 15-30 rain after inoculation. Three-five mice per group were sacrificed at each 
time period and organs from individual mice homogenized in 5 ml HBSS using a Ten Brock 
grinder. Homogenates were diluted in HB SS and duplicate pour plates were made using trypti- 
case soy agar. Plates were counted after 24-h incubation at 37°C. 
Immunization.--Mice were immunized with a sublethal dose of Listeria (2  X  103-5 X  10 a) 
given intravenously. Splenic lyrnphocytes for transfer were harvested 8 days after inoculation 
with bacteria. 
Preparation of Spleen  Cell Suspensions.--Singie  cell suspensions were prepared by gently 
pressing spleens through stainless steel mesh screens into HBSS  containing 1% fetal  calf 
serum (FCS). Particulate material was allowed to sediment and the supernate removed and 
centrifuged at 300 g for 5 rain. The pellet was resuspended in 5 volumes of 0.83% NH4C1 
and incubated at 37°C for 15 rain. This procedure lysed the red blood cells without affecting 
the viability of the lymphocytes. The cells were then washed twice and resuspended in HBSS 
with 1% FCS. 
Cells to be incubated with SSF were resuspended in 5% FCS in minimal essential medium 
(MEM) at a concentration of 5  X  107 cells/ml. SSF was then added at a concentration of 1-2 
mg/ml and the cultures incubated at 37°C for 2 h. They were then washed twice and resus- 
pended in HBSS with 1% FCS for injection. The standard inoculum was 1 X  l0 s cells given 
intravenously in a  volume of 0.5 ml. Viability was tested by trypan blue exclusion and was 
consistently greater than 85%. 
Rabbit Anti-SSF Serum.--New Zealand white rabbits were immunized with 2 ml SSF  (1 
mg/ml) emulsified in an equal volume of complete Freund's adjuvant. Three weekly injections 
were administered intramuscularly in both thighs and subcutaneously in the nape of the neck. 
Rabbits were bled 7-10 days after the last injection. Serum was inactivated by heating to 822  SEA  STAR COELOMOCYTE EXTRACT AND  CELLULAR IMMUNITY 
56°C  for 30  min, and assayed for precipitating antibody by immunodittusion. The serum 
showed a strong precipitin line at a 1: 80 dilution when reacted with SSF at a concentration of 
0.5 mg/ml. 
RESULTS 
Enhancement  of  Listeria  Infection  by  Treatment  with  SSF.--Preliminary 
experiments  indicated  that  SSF  treatment  did  not  protect  mice  against  a 
lethal  challenge  with  Listeria  and,  in  fact,  may  have  increased  their  sus- 
ceptibility. To determine if this were indeed the case, mice were injected with 
0.5 ing SSF intravenously 24 h before infection with a sublethal dose (6 X  103) 
of Listeria.  As shown in Fig.  1,  normal mice began to dear the infection at 
48  h.  SSF-treated mice,  however, failed to clear  the  infection, and  at  72  h 
there were 3 log units more organisms in the livers and 1.5 log units more in 
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FIG. 1. Growth curves of a sublethal dose (6 X  103) of Listeria in livers and spleens of mice 
given 5 mg SSF 24 or 96 h before infection. Means of three mice per time point. DAVID  O.  WILLENBORG  AND  ROBERT  A.  PRENDERGAST  823 
the spleens of treated mice than in normal mice. By 96 h, SSF-treated mice had 
succumbed to the infection. Fig. 1 also shows that this enhancing effect of SSF 
was seen even when it was given 4 days before infection. 
To further investigate the relationship between time of SSF treatment and 
enhancing effect, mice were injected with 8 X  103 Listeria, and then given 0.5 
mg SSF  either 24 or 48 h  after injection. Again,  the growth of organisms in 
normal mice peaked at 48 h and then began to decline (Fig. 2). In  SSF-treated 
mice the organisms continued to grow, and all  were dead by 96 h. Thus, 0.5 
mg SSF given to mice 96 h before to 48 h after infection with  a  sublethal  dose 
of Listeria led to uncontrolled growth of the organisms and death. 
Dose-Response Relationship.--Previous  studies  in  this laboratory indicated 
that high concentrations of SSF would destroy cultured macrophages,  either 
through a toxic effect or by activating the cells to the extent that they under- 
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FIG. 2. Growth curves of a sublethal dose (8 X  108) of Listeria in livers and spleens of mice 
given 0.5 mg SSF 24 or 48 h  after infection. All SSF-treated mice died after 72 h. Means of 
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went autolysis. We therefore examined the effect of various doses of SSF  on 
resistance to infection. 
Mice  were  given  2.0,  0.5,  0.25,  0.1,  or  0.01  mg  SSF  intravenously  24  h 
before  infection  with  a  sublethal  dose  of Listeria.  Livers  and  spleens  were 
harvested  and  assayed  for  bacteria  at  24,  48,  and  72  h  postinfection.  The 
results shown  in  Fig.  3  demonstrate  that  doses of SSF  of 0.1  mg or greater 
enhanced infection. Treated mice began dying between 48 and 72 h, and only 
one mouse in the groups receiving 0.25  and 0.1  mg SSF was alive for assay at 
72 h. Mice treated with 0.01  mg SSF did not differ significantly from normal 
mice. All doses of SSF employed in this experiment were below that which had 
been  shown  to  destroy macrophages in  vitro.  It  is  unlikely,  therefore,  that 
the enhancing effect of SSF on Listeria infection was through the destruction 
of macrophages. 
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Fio. 3. Curves showing the effect of various doses of SSF on the growth of a  sublethal dose 
of Listeria.  SSF was given 24 h  before infection. Mice receiving 0.5 or 2.0 mg SSF died after 
48 h. Means of three mice. 
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Effect  of SSF  on Established  Immunity.--In  order to further examine  the 
effect of SSF on macrophages, the following experiment was performed. Mice 
were immunized with a sublethal (5  X  103) dose of Listeria.  7 days later,  one 
half the mice were given 0.5 mg SSF intravenously. On day 8, the SSF-treated 
and the untreated mice were challenged with a  lethal dose of Listeria  (2  X 
105). The results are shown in Fig. 4. Immune mice given SSF before challenge 
were equally as efficient in  clearing the infection as were immune mice  not 
given SSF. 
If  the  enhancing  effect of  SSF  were  due  to  destruction  of macrophages, 
then its effect should be independent of the immune status  of the mice;  i.e., 
without  macrophages,  immune  mice  should  be  just  as  susceptible  as  non- 
immune mice. The present experiment demonstrates that this is not the  case. 
LIVER  SPLEEN 
8[  8 
7  7 
6  NORMAL  6  NORMAL 
IMMUNE  + SSF  MUNE 
2  2l  ~MMuNE ÷ SSF 
I  i  =  I  I  M 
24  48  "7?_  24  48  72 
HOURS  HOURS 
FIG.  4.  Growth curves showing the inability of SSF to alter established immunity. Mice 
were immunized with a  sublethal dose of Listeria on day 0. On day 7, one-half the immune 
mice were given 0.5 mg SSF intravenously. 24 h  later, both treated  (immune -4- SSF)  and 
nontreated (immune) mice were challenged with a lethal dose of Listeria. Means of five mice. 826  SEA  STAR COELOMOCYTE EXTRACT AND  CELLULAR IMMUNITY 
Effect of SSF on the Afferent Limb of the Immune Response.  -Whether  SSF 
prevents immunization was next examined. Mice were given 0.5  mg SSF  in- 
travenously on day 0. 24 h later they were injected with a small dose (8 ×  llY) 
of Listeria. Another group of mice received only the 8 X  102 Listeria. On day 10, 
both groups were challenged with a lethal dose of organisms, as was  a  group 
of normal mice. 
The results of this experiment are presented in Fig. 5. The organisms grew 
rapidly in normal mice as shown previously. Mice that had been immunized 
with 8  X  10  ~ Listeria were immune to challenge,  whereas those  that had re- 
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FIG. 5. Growth curves describing the inhibitory effect of SSF on immu_n~.afion of mice with 
laisteria.  Mice were given 0.5  mg SSF 24  h  before an immunizing infection with 8  X  10  s 
Listeri~ (SSF q- immunization). Another group of mice received only the immunizing infec- 
tion (immunization). i0 days later, both groups were challenged with a lethal dose of Listeria 
as was a group of normal mice. As a control for the persistence of SSF in quantities sufficient 
to enhance infection, another group  of mice was given 0.5  mg SSF  (SSF alone)  and  then 
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ceived SSF 24 h before the immunizing injection failed to develop  immunity, 
as evidenced by the rapid growth of the organisms in these animals. Another 
group of mice that had received SSF alone on day 0 and challenged with a  sub- 
lethal dose of organisms on day 10 behaved like untreated animals receiving a 
sublethal  dose,  indicating  that  SSF  did  not persist,  for  the  10  days of  the 
experiment, in quantities sufficient to enhance infection. 
It should be noted here that because of the enhancing effect of SSF,  20 % 
of the SSF-treated mice that received the low immunizing dose of Listeria de- 
veloped a lethal infection. The other 80 % survived and managed to clear most 
of the infection by day 10.  Clearance in  these mice, however, was not com- 
plete,  as evidenced by the higher initial  implantation values determined 30 
rain  after  the  challenge  infection.  It  is  unlikely,  however,  that  this  higher 
initial implantation value could in itself account for the extreme difference in 
bacterial growth between immunized mice and mice immunized in the presence 
of SSF. 
Eject of SSF on the Adoptive  Transfer of Immunity.--The previous experi- 
ment  demonstrated  that  SSF  inhibits  immunization.  In  order  to  examine 
whether  SSF  modifies the  action of effector lymphocytes, its  action  on  the 
adoptive transfer of immunity was studied. 
Spleen cells from 8-day Listeria immune mice were prepared as described in 
Materials and Methods. Cells were suspended in MEM containing 5 % FCS at 
a concentration of 5 X  107 cells/ml. 1 mg/ml SSF was added and the cell sus- 
pension incubated at 37°C for 2 h. The cells were then washed twice, counted, 
and adjusted to a concentration of 2 X  l0  s cells/ml. Viability after incubation 
was  always greater than 85 %. Normal mice were given 1  X  los immune or 
SSF-treated immune cells intravenously in a volume of 0.5  ml. 1 h later both 
groups,  as  well  as  a  control  group  of mice  receiving no  cells,  were given  a 
lethal dose of Listeria  (5 X  104). In earlier adoptive transfer experiments, con- 
trol mice received normal  spleen cells which regularly failed to transfer any 
immunity. For the sake of conserving mice, all future experiments employed 
normal mice without nonimmune cells as controls. 
The results shown in Fig. 6 indicate that a considerable degree of immunity 
was  conferred by both immune  cells  and SSF-treated immune cells.  Thus it 
appears that once the lymphocytes have been sensitized, SSF is not able to shut 
off the expression of the immunity. 
Inhibition  of Adoptive  Transfer by SSF-treated Immune Cells with Anti-SSF 
and Complement (C).--Listeria immune spleen cells were incubated at a concen- 
tration of 5 )< 107 cells/ml in the presence of 1 mg/ml SSF for 1 h at 37°C. The 
cells were then washed twice with HBSS, adjusted to a concentration of 1 X  108 
cells/ml divided into 1-ml aliquots, and centrifuged. They were then suspended 
in 1 ml of either anti-SSF and C or normal rabbit serum (NRS) and C. The final 
concentration of both serum and C  was  1:10. After 1 h  incubation at 37°C, 
the cells were washed twice in HBSS, tested for viability with trypan blue, and 828  SEA  STAR COELOMOCYTE EXTRACT AND  CELLULAR IMMUNITY  SPLEEN 
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FIG. 6. Curves showing the effect of treatment of immune lymphocytes with SSF on adop- 
tive transfer of immunity. Spleen cells from 8-day immune mice were incubated with 1 mg/ 
ml SSF for 2 h at 37°C. They were washed and then transferred into normal recipients at a 
concentration  of  1 X 108 cells/mouse. Recipients of immune cells or SSF-treated immune 
cells were challenged with a lethal dose of Listeria 1 h after cell transfer. The normal controls 
did not receive spleen cells. Means of five mice. 
injected into normal recipients at a concentration of 1 X  108 cells/mouse. Non- 
treated  immune cells were injected into another group  of  recipients, and all 
mice were challenged with 3  X  108 Listeria 1 h  after cell injection. 
The results, presented in Fig.  7,  show  that immune cells and  SSF-treated 
immune cells  treated  with NRS  and  C  both  conferred a  high degree  of  im- 
munity on normal recipients. SSF-treated immune cells that had  been incu- 
bated with anti-SSF and C lost their ability to transfer immunity, and growth 
of  the  organisms in recipients of  these  cells  was  similar  to  that  in  control 
animals which received no cells. Incubation of cells with NRS and C  reduced 
the  total viable cell  number by about  10%.  The same decrease  was  seen in 
nontreated cells after incubation. Incubation with anti-SSF and C,  however, 
decreased the viable cell count by 35-40 %. DAVID  O.  WILLENBORG  AND  ROBERT  A.  PRENDERGAST 
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FIG. 7. Growth curves showing the inhibition of adoptive transfer by SSF-treated immune 
cells with anti-SSF and C. Spleen cells from 8-day immune mice were incubated with 1 mg/ 
ml SSF for 1 h at 37°C,  washed, and then incubated with either anti-SSF and C  or normal 
rabbit serum and C for 1 h at 37°C.  1 X  10 s viable cells were transferred to normal recipients. 
1 h  later, mice were challenged with a  lethal dose of Listeria.  Immune indicates nontreated 
immune cells. Controls received no cells. Means of five mice. 
DISCUSSION 
Immunity to Listeria in mice has been shown to be ultimately a function of 
macrophages  (1)  which  have  become  activated  by  a  process  that  depends 
on specific interaction between immune lymphoid cells and the infecting orga- 
nism (2,  10).  However, host resistance may also be modified and strikingly 
increased by nonspecific means (11-14).  The mechanism of macrophage acti- 
vation,  either  specific  or  nonspecific,  and  the  functional  and  biochemical 
changes  accompanying  activation  remain  largely  unknown.  One  possible 
method of activation is through the release by lymphocytes of humoral sub- 
stances, similar or identical to the lymphokines described for in vitro models of 
delayed hypersensitivity. 
SSF  is  a  protein  isolated from the  coelomocytes of A. forbesi  which  has 
macrophage-activating properties  as well  as other lymphokine-like activities 
(6,  7). We employed SSF as a macrophage-activating substance in an attempt 830  SEA  STAR  COELOMOCYTE  EXTRACT  AND  CELLULAR  IMMUNITY 
to increase the resistance of mice to Iisteriosis. Immunity to Listeria infection 
was  severely depressed  by  treatment  of  mice  with  SSF.  Injection  with  as 
little as 0.1  mg SSF produced uncontrolled growth of an otherwise sublethal 
dose of Listeria and resulted in death. This enhancing effect could be demon- 
strated when SSF was given from 96 h before to 48 h after infection. 
Previous observations in this laboratory  ~ indicated that treatment of macro- 
phages in vitro with high concentrations of SSF resulted in destruction of the 
cells. However, the effects of SSF described here were probably not due to the 
destruction of macrophages for several reasons.  (a) The doses of SSF used in 
vivo were well  below  the concentration shown to cause  destruction in vitro. 
The numbers of bacteria initially taken up by the livers and spleens of both 
normal  and  SSF-treated mice were identical,  indicating  that  the phagocytic 
function  of  macrophages  in  SSF-treated  mice  was  not  impaired.  (c)  If  the 
enhancing effect of SSF were due to the destruction of macrophages, then this 
effect should  be  independent  of  the  immune  status  of  the mice,  since  both 
normal and immune mice depend on functional, activated macrophages for their 
resistance. That this clearly was not the case is shown in Fig. 4, where treat- 
ment of immune mice with SSF before challenge with a lethal dose of Listeria 
did not alter their immune status. 
Treatment of immune lymphocytes in vitro with SSF did not destroy their 
ability to adoptively transfer immunity to normal recipients (Fig. 6). However, 
if SSF  was  given  to mice before infection with  a  small  immunizing dose of 
Listeria,  they failed to develop immunity, as evidenced by their susceptibility 
to a subsequent challenge. These data suggest that SSF acts as a suppressor of 
lymphocyte  function,  possibly  by  preventing  replication  and  subsequent 
sensitization, but has no effect on committed, or effector, lymphocytes. 
The above suggestion draws support from recent work demonstrating that 
the proliferative response of human peripheral blood lymphocytes stimulated 
by phytohemagglutinin and  concanavalin A  (Con A) was inhibited by micro- 
gram  quantities  of SSF  added  to  the  reaction mixture.  In  addition,  it was 
shown  that  the effector function of splenic lymphocytes was not  altered by 
treatment with  SSF  (15). The effector function measured was  the ability of 
splenic l)anphocytes from lymphocytic choriomeningitis (LCM) virus-immune 
mice  to lyse target L  cells infected with LCM  virus.  Incubation of immune 
lymphocytes  with  SSF  did  not  inhibit  their  ability  to  lyse  virus-infected 
cells. 
A  number of investigators (16-20)  have demonstrated  the thymus  (T-cell) 
dependency of resistance to Listeria infection. Treatment of immune lympho- 
cytes with anti-0 serum and C has been shown to destroy the ability of these 
cells to adoptively transfer immunity to normal recipients (16). In the present 
study, treatment of immune lymphocytes with SSF did not alter their ability 
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to  transfer immunity.  However,  if  immune  lymphocytes were  treated  with 
SSF and then incubated with anti-SSF and C, the ability to transfer immunity 
was lost. We interpret this observation to mean that SSF binds to T  lympho- 
cytes. We have no direct evidence of the T-cell specificity of binding in this 
experiment, and SSF may also bind to B lymphocytes. However, the viability 
studies indicated that, at most, 40 % of the SSF-treated cells were destroyed by 
treatment with anti-SSF and C. This is approximately the percent of T  cells 
one would expect to find in a  spleen cell population. If SSF binds equally as 
well to B cells as to T  cells,  then a greater proportion of the total cell popula- 
tion should have been destroyed. 
The T-cell specificity of SSF, however, is demonstrated in another system 
described by Prendergast et al. (15). Destruction of DBA/2 mastocytoma cells 
by spleen  cells  from  C57B1/6  mice  immunized  with  the  mastocytoma  is  a 
T-cell-dependent response  (21,  22).  SSF  injected into  C57B1/6  mice  at  the 
time they received mastocytoma cells prevented the development of lympho- 
cytes  cytotoxic for  these  cells.  If  SSF-treated  mice  were  immunized  with 
pneumococcal polysaccharide, they developed a normal antibody response to 
this T-cell-independent antigen. 
An  apparent  paradox  exists  with  regard  to  the  effect of  SSF  on  macro- 
phages.  In vitro, SSF is  a  potent macrophage activator, while in vivo it ap- 
pears to have little activity as evidenced by its inability to enhance protection 
against Listeria. One explanation could be that the concentration of SSF that 
contacts macrophages in vivo is not sufficient to cause activation. More im- 
portanL however, is the effect of SSF on lymphocytes. SSF apparently binds 
to T  lymphocytes, prevents their replication upon contact with Listeria anti- 
gens, and thus abrogates the generation of a population of sensitized lympho- 
cytes  that  ultimately  activate  macrophages.  This  inhibition  of  the  T-cell 
response  apparently  outweighs  any  primary  macrophage-activating  effect 
that SSF may have in vivo. 
Studies are now in progress to more clearly define the T-cell specificity of 
SSF and to examine other systems where SSF may be used to inhibit T-lympho- 
cyte-dependent immune responses, e.g., graft-vs.-host reactions and antibody 
production to T-cell-dependent antigens. 
SUMMARY 
Mice treated with sea star factor (SSF), a  protein extracted from sea star 
coelomocytes, became  highly  susceptible  to  infection with  a  normally  sub- 
lethal  dose  of Listeria monocytogenes.  This  was  in  contrast  to  the  expected 
result of increased resistance originally postulated because of the macrophage- 
activating properties of SSF. Enhanced susceptibility was seen when SSF was 
given from 96 h  before to 48 h  after infection with Listeria.  Mice pretreated 
with SSF failed to develop immunity to Listeria when given a dose of organisms 
capable  of  immunizing  nontreated  mice.  Treatment  of  immune  mice  with 832  SEA  STAR  COELOMOCYTE  EXTRACT  AND  CELLULAR  IMMUNITY 
SSF  did  not  alter  their  immune  status.  In  addition,  incubation  of immune 
lymphocytes with SSF in vitro did not alter their ability to adoptively transfer 
immunity to normal  recipients.  Immune lymphocytes treated  with  SSF  and 
then incubated with anti-SSF and C did, however, lose  the ability to transfer 
immunity. These results suggest that SSF enhances infection by binding to T 
lymphocytes, inhibiting  their  replication  upon  contact with  Listeria  antigen 
and thus preventing the generation of a population of sensitized lymphocytes 
capable of effecting anti-Lisleria immunity. 
REFERENCES 
1.  Mackaness,  G.  B.  1970. The monocyte in  cellular  immunity.  Semin.  ttematol. 
7:172. 
2.  Mackaness,  G. B.  1969. The influence of immunologically committed  lymphoid 
cells on macrophage activity in vivo. J. Exp. Med. 129:973. 
3.  Tripathy, S. P.,  and  G. B.  Mackaness.  1969. The effect of cytotoxic  agents  on 
the passive transfer of cell-mediated immunity. J. Exp. Med. 130:17. 
4.  Blanden, R. V., M. J. Lefford, and G. B. Mackaness.  1969. The host response to 
Calmette-Gu6rin  bacillus infection in mice. J. Exp. Med. 129:1079. 
5.  Dumonde,  D.  C.,  R.  A. Wolstencroft,  G.  S.  Panayi, M.  Matthew,  J.  Morley, 
and W. T. Howson. 1969. "Lymphokines": Nonantibody mediators  of cellular 
immunity generated by lymphocyte activation.  Nature (Lond.). 224:38. 
6.  David, J.  R.,  and R. A. David.  1972. Cellular  hypersensitivity  and immunity. 
Inhibition  of  macrophage  migration  and  the  lymphocyte mediators.  Prog. 
Allergy. 16:300. 
7.  Prendergast,  R. A., and M. Suzuki.  1970. Invertebrate protein  simulating medi- 
ators of delayed hypersensitivity.  Nature (Lond.). 297:277. 
8.  Prendergast,  R. A., and E. R. Unanue.  1970. Macrophage activation and migra- 
tion inhibitory factor from the sea star A. forbesi. Fed. Proc. 29:771. 
9.  Cohn, Z.  A.  1968. The structure  and function  of monocytes  and macrophages. 
Adv. Immunol.  9:163. 
10.  Mackaness,  G. B., and W. C. Hill. 1969. The effect of antilymphocyte globulin 
on cell-mediated resistance to infection. J. Exp. Meal. 129:993. 
11.  Mackaness,  G. B.  1962. Cellular resistance  to infection. J. Exp. Med.  116:381. 
12.  Ruskin,  J.,  and J.  S.  Remington.  1968. Role  for the  macrophage  in  acquired 
immunity to  phylogenetically  unrelated  intracellular  organisms.  Antimicrob. 
Agents Chemother. 8:474. 
13.  Ruskin,  J.,  and J.  S.  Remington.  1968. Immunity and  intracellular  infection: 
Resistance  to  bacteria  in  mice  infected  with  a  protozoan.  Science (Wash. 
D.C.). 160:72. 
14.  Ellberg, S. S. 1960. Cellular immunity.  Bacteriol. Rev. 24:67. 
15.  Prendergast,  R.  A.,  G. A. Cole, and  C.  S. Henney.  1974. Marine  invertebrate 
origin of a reactant to mammalian T cells. Ann. N. Y. Acad. Sci. In press. 
16.  Lane,  F. C., and E. R. Unanue.  1972. Requirement  of thymus (T) lymphocytes 
for resistance to listeriosis. J. Exp. Meal. 135:1104. 
17.  Youdim, S., O. Stutman, and R. A. Good. 1973. Studies of delayed hypersensitivity 
to L. monocytogenes in mice: nature of cells involved in passive transfer.  Cell. 
Immunol.  6:98. DAVID O.  WILLEN-BORG  AND ROBERT A.  PRENDERGAST  833 
18.  Youdim,  S.,  O.  Stutman,  and  R.  A.  Good.  1973. Thymus dependency of cells 
involved in  transfer  of delayed hypersensitivity  to Listeria  monocytogenes  in 
mice. Cell. Immunol. 8:395. 
19.  North,  R. J.  1973. Cellular mediators of anti-Listeria  immunity as an enlarged 
population of sh0rt-lived replicating T  cells. J. Exp. Med. 188:342. 
20.  Blanden, R. V., and R. E. Langman. 1972. Cell-mediated immunity to bacterial 
infection in the mouse. Thymus-derived cells as effectors of acquired resistance 
to Listeria monocytogenes. Seand. J. Immunol. 1:379. 
21.  Cerottini, J.-C., A. A. Nordin, and K. T. Brunner.  1970. In vitro cytotoxic ac- 
tivity of thymus cells sensitized  to alloantigens. Nature (Lond.) 227:72. 
22.  Cerottini, J.-C.,  A. A. Nordin, and K. T. Brunner.  1970. Specific in vitro cyto- 
toxicity  of  thymus-derived  lymphocytes  sensitized  to  alloantigens.  Nature 
(Lond.)  228:13o8. 